RAPT THERAPEUTICS INC. - COMMON STOCK

RAPT Therapeutics Announces Pricing of Public Offering of Common Stock

15 يونيو 2021 23:07:25 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Announces Proposed Public Offering of Common Stock

14 يونيو 2021 16:01:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis

14 يونيو 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Report Top Line Data from Phase 1b Trial of RPT193 in Atopic Dermatitis

13 يونيو 2021 16:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the UBS Global Healthcare Virtual Conference

20 مايو 2021 16:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports First Quarter 2021 Financial Results

11 مايو 2021 08:00:02 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Completes Enrollment in Phase 1b Trial of RPT193 in Atopic Dermatitis

22 مارس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results

11 مارس 2021 08:00:02 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Report Promising Preclinical Studies Supporting its Pipeline of Immunotherapy Platforms at AACR

10 مارس 2021 16:30:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Participate in Two Investor Conferences in March

03 مارس 2021 08:00:01 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

19 فبراير 2021 08:00:00 بحسب Nasdaq GlobeNewswire

RAPT Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

05 يناير 2021 08:00:01 بحسب Nasdaq GlobeNewswire